A major new study published in Neurology demonstrated that individuals with higher circulating vitamin D levels during midlife showed significantly lower tau protein accumulation in the brain nearly two decades later. Tau protein accumulation is one of the central pathological hallmarks of Alzheimer’s disease and other neurodegenerative disorders. These findings suggest vitamin D optimization during midlife may represent an overlooked but potentially powerful intervention for

Creatine is widely used to improve muscle mass and athletic performance, but it may not be appropriate for everyone. While generally considered safe in healthy individuals, concerns remain for patients with kidney disease, diabetes, hypertension, dehydration, or those taking medications that affect renal function. This article reviews potential risks, explains who should exercise caution, and discusses safer alternatives for preserving muscle mass and healthy aging.

Metabolic syndrome marks the point where insulin resistance becomes measurable disease. At this stage, the process remains highly reversible. Early detection and targeted intervention can prevent progression to heart disease, diabetes, and cognitive decline.

Insulin resistance develops silently years before diabetes, accelerating heart disease, cognitive decline, and aging. Early detection with proper lab testing allows effective, targeted intervention to reverse risk and restore metabolic health.

Visceral fat is not merely stored energy—it is a biologically active tissue that drives insulin resistance, cardiovascular disease, cognitive decline, and accelerated aging. Many individuals with normal weight harbor excess visceral fat. Identifying and reducing it early can dramatically improve metabolic health and long-term healthspan.

Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly called fatty liver, is not a liver problem alone—it is a systemic marker of insulin resistance. Often silent for years, MASLD signals elevated cardiometabolic, cognitive, and longevity risk long before abnormal liver enzymes or diabetes appear.

Insulin resistance often develops years before diabetes, heart disease, or dementia are diagnosed. During this silent phase, metabolic dysfunction damages blood vessels, the brain, and cellular aging pathways. Understanding insulin resistance early allows for targeted intervention that can meaningfully reduce cardiovascular risk, cognitive decline, and accelerated biological aging.

Lactoferrin-rich colostrum occupies a unique niche at the intersection of mucosal immunity, systemic inflammatory control, and sleep regulation. By combining the broad matrix of colostrum with the targeted antiviral, antibacterial, and immunomodulatory activity of lactoferrin, these preparations can reduce the burden of upper respiratory infections, support resilient immune function, and modestly improve sleep quality in selected populations. As with any therapeutic nutrient,